VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 121 filers reported holding VIKING THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $283 | -77.7% | 25,528 | -67.4% | 0.03% | -71.1% |
| Q2 2023 | $1,268 | -97.2% | 78,229 | +361.8% | 0.10% | +2325.0% |
| Q3 2022 | $46,000 | -20.7% | 16,941 | +34.1% | 0.00% | -33.3% |
| Q4 2021 | $58,000 | -57.7% | 12,633 | -44.9% | 0.01% | -53.8% |
| Q2 2021 | $137,000 | -34.4% | 22,929 | -38.3% | 0.01% | -43.5% |
| Q4 2020 | $209,000 | +127.2% | 37,152 | +191.1% | 0.02% | +109.1% |
| Q2 2020 | $92,000 | +10.8% | 12,761 | +5.7% | 0.01% | +83.3% |
| Q3 2019 | $83,000 | -50.6% | 12,071 | -40.3% | 0.01% | -40.0% |
| Q2 2019 | $168,000 | -89.7% | 20,236 | -87.6% | 0.01% | -89.1% |
| Q1 2019 | $1,628,000 | +1124.1% | 163,782 | +844.3% | 0.09% | +1214.3% |
| Q4 2018 | $133,000 | -71.8% | 17,344 | -35.9% | 0.01% | -75.9% |
| Q3 2018 | $472,000 | -11.9% | 27,073 | -52.1% | 0.03% | +20.8% |
| Q2 2018 | $536,000 | +665.7% | 56,533 | +54.5% | 0.02% | +700.0% |
| Q3 2017 | $70,000 | – | 36,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $2,613,000 | 6.32% |
| Opaleye Management Inc. | 825,000 | $14,371,000 | 3.66% |
| Prosight Management, LP | 274,410 | $4,780,000 | 2.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 859,727 | $14,976,000 | 1.72% |
| KNOTT DAVID M | 236,600 | $4,122,000 | 1.34% |
| Sio Capital Management, LLC | 213,252 | $3,715,000 | 1.28% |
| NEXTHERA CAPITAL LP | 327,730 | $5,709,000 | 1.09% |
| EAM Global Investors LLC | 115,781 | $2,017,000 | 0.82% |
| Nicholas Investment Partners, LP | 580,028 | $10,104,000 | 0.81% |
| Park West Asset Management LLC | 1,269,107 | $22,108,000 | 0.80% |